Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease

JAMA Cardiology

Volumn 2, Issue 6, 2017, Pages 635-643

  Chen, Jing ^a,b   Budoff, Matthew J ^c   Reilly, Muredach P ^d   Yang, Wei ^e   Rosas, Sylvia E ^f   Rahman, Mahboob ^g   Zhang, Xiaoming ^e   Roy, Jason A ^e   Lustigova, Eva ^b   Nessel, Lisa ^e   Ford, Virginia ^e   Raj, Dominic ^h   Porter, Anna C ⁱ   Soliman, Elsayed Z ^j   Wright, Jackson T ^g   Wolf, Myles ^k   He, Jiang ^a,b   Appel, Lawrence J ^l   Feldman, Harold I ^m   Go, Alan S ⁿ   Kusek, John W ^o   Lash, James P ⁱ   Ojo, Akinlolu ^p   Townsend, Raymond R ^m   more..

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

ⁱ UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ DIVISION OF RESEARCH   (United States)

^o NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^p UNIVERSITY OF MICHIGAN   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; TROPONIN T;

ADULT; AGED; ALL CAUSE MORTALITY; ANTIHYPERTENSIVE THERAPY; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL EFFECTIVENESS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTRON BEAM TOMOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; REVIEW; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED STATES; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; INCIDENCE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY; YOUNG ADULT;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 85020559036     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.0363     Document Type: Review

References (35)

1. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339-352.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
3. Matsushita K, van der Velde M, Astor BC, et al; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborativemeta-analysis. Lancet. 2010;375 (9731):2073-2081.
4. Hemmelgarn BR, Manns BJ, Lloyd A, et al; Alberta Kidney Disease Network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423-429.
5. He J, Reilly M, Yang W, et al; CRIC Investigators. Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). Am J Cardiol. 2012;110(12):1735-1741.
6. Kestenbaum BR, Adeney KL, de Boer IH, Ix JH, Shlipak MG, Siscovick DS. Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis. Kidney Int. 2009;76(9):991-998.
7. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 2004;44:1024-1030.
8. Greenland P, Bonow RO, Brundage BH, et al; American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007;115:402-426.
9. Peters SA, Bakker M, den Ruijter HM, Bots ML. Added value of CAC in risk stratification for cardiovascular events: a systematic review. Eur J Clin Invest. 2012;42(1):110-116.
10. Bashir A, Moody WE, Edwards NC, Ferro CJ, Townend JN, Steeds RP. Coronary artery calcium assessment in CKD: utility in cardiovascular disease risk assessment and treatment? Am J Kidney Dis. 2015;65(6):937-948.
11. Matsushita K, Sang Y, Ballew SH, et al. Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J AmSoc Nephrol. 2015;26(2):439-447.
12. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25)(suppl 2):S49-S73.
13. Lash JP, Go AS, Appel LJ, et al; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J AmSoc Nephrol. 2009;4(8):1302-1311.
14. Pickering TG, Hall JE, Appel LJ, et al; Council on High Blood Pressure Research Professional and Public Education Subcommittee, American Heart Association. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005; 7(2):102-109.
15. Anderson AH, Yang W, Hsu CY, et al; CRIC Study Investigators. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis. 2012;60(2):250-261.
16. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J AmColl Cardiol. 1990;15(4):827-832.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J AmStat Assoc. 1958;53(282):457-481.
18. Cox DR. Regression models and life tables. J Royal Stat Soc Series B. 1972;34:187-188, 220.
19. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13): 2109-2123.
20. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11-21.
21. Wilkieson TJ, Rahman MO, Gangji AS, et al. Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis. Can J Kidney Health Dis. 2015;2:29.
22. Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303(16):1610-1616.
23. Cho I, Min HS, Chun EJ, et al. Coronary atherosclerosis detected by coronary CT angiography in asymptomatic subjects with early chronic kidney disease. Atherosclerosis. 2010;208 (2):406-411.
24. Joosen IA, Schiphof F, Versteylen MO, et al. Relation between mild to moderate chronic kidney disease and coronary artery disease determined with coronary CT angiography. PLoS One. 2012;7 (10):e47267.
25. Winther S, Svensson M, Jorgensen HS, et al. Diagnostic performance of coronary CT angiography andmyocardial perfusion imaging in kidney transplantation candidates. JACC Cardiovasc Imaging. 2015;8(5):553-562.
26. Russo D, Corrao S, Battaglia Y, et al. Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int. 2011;80(1):112-118.
27. Baber U, de Lemos JA, Khera A, et al. Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort. Kidney Int. 2008;73(5): 615-621.
28. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10-E17.
29. Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89(12):1147-1154.
30. Goodman WG, London G, Amann K, et al; Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;43(3):572-579.
31. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial. 2007;20(2):103-109.
32. Wade AN, Reilly MP. Coronary calcification in chronic kidney disease: morphology, mechanisms and mortality. Clin J AmSoc Nephrol. 2009;4(12): 1883-1885.
33. Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: intima versus media. Herz. 2001;26(4):245-251.
34. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117(22):2938-2948.
35. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-1740.